Soleo Health, a provider of complex speciality pharmacy services, has launched a new ambulatory infusion suite (AIS) in Fort Wayne, Indiana, US.
Offering flexible appointment times, the AIS is also situated near major healthcare providers in the area to serve patients with complex and rare conditions.
Go deeper with GlobalData
Patients and medical providers can schedule appointments, including weekend slots, by calling the facility directly or through referrals.
The newly opened AIS is operated by registered nurses who specialise in treating patients with a range of complex conditions.
These conditions include chronic inflammatory demyelinating polyneuropathy (CIDP), dermatomyositis, primary immunodeficiencies (PI), myasthenia gravis (MG) and thyroid eye disease (TED).
The suite also supports the treatment of multiple sclerosis (MS), Crohn’s disease, rheumatoid arthritis (RA), and ulcerative colitis (UC).
Soleo Health chief commercial officer Craig Vollmer said: “We are excited to offer additional services in the Fort Wayne market. An increasing number of patients and providers are finding that alternate sites of care – such as an AIS – can seamlessly, easily and conveniently address their needs.
“By further cementing Soleo Health’s presence in Indiana with our new AIS and complementing our home infusion service offering, we will demonstrate to both patients and providers across the greater Fort Wayne community our experience and clinical excellence as well as our abilities in simplifying complex care.”
Soleo Health currently operates more than 30 infusion suites and centres in the US. Last month, the company received a joint investment from Court Square Capital Partners and WindRose Health Investors.
In January 2025 and December 2024, Soleo Health opened new AISs in the metro Denver area and Farragut, Tennessee, respectively.
